Clinical Research Directory
Browse clinical research sites, groups, and studies.
Psilocybin With Intracranial Neural Sensing
Sponsor: Joshua Woolley, MD, PhD
Summary
This is an open-label, single-arm, pilot study exploring the neural, sensory, and cognitive effects of a single, medium dose of psilocybin in patients with chronic pain who already have implanted sensing-capable deep brain stimulation (DBS) devices. Outcomes include multi-site neural recording from previously placed ambulatory sensing-capable DBS devices, quantitative sensory and cognitive testing, and self-reports of pain. We hypothesize that psilocybin will change functional connectivity, decrease clinical and task-based pain reports, and improve cognitive functions.
Key Details
Gender
All
Age Range
21 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-06-01
Completion Date
2028-04-30
Last Updated
2025-06-06
Healthy Volunteers
No
Conditions
Interventions
Psilocybin
10mg oral psilocybin
Locations (1)
University of California, San Francisco
San Francisco, California, United States